Clinical Trials Sponsored by BioMarck Pharmaceuticals, Ltd
Total 4500 results
-
BioMarck Pharmaceuticals, Ltd.CompletedRespiratory Distress Syndrome, AdultUnited States
-
BioMarck Pharmaceuticals, Ltd.CompletedNon Small Cell Lung Cancer Stage IIIBIndia
-
BioMarin PharmaceuticalRecruitingIdiopathic Short StatureUnited States
-
BioMarin PharmaceuticalRecruitingPhenylketonuria (PKU)United States, Germany, Italy
-
BioMarin PharmaceuticalRecruitingHemophilia A With Inhibitor | Hemophilia A With Anti Factor VIIIUnited States, United Kingdom, Taiwan, Korea, Republic of, Brazil, Italy
-
BioMarin PharmaceuticalActive, not recruitingHemophilia AUnited States, Australia, Taiwan, Brazil
-
BioMarin PharmaceuticalActive, not recruitingAchondroplasiaUnited States, Australia, Japan, United Kingdom
-
BioMarin PharmaceuticalActive, not recruitingAchondroplasiaAustralia, United Kingdom
-
BioMarin PharmaceuticalActive, not recruitingHemophilia A | Gene Therapy | Blood Disorder | Clotting DisordersTaiwan, Korea, Republic of, United Kingdom, South Africa
-
BioMarin PharmaceuticalActive, not recruiting
-
BioMarin PharmaceuticalActive, not recruiting
-
BioMarin PharmaceuticalCompletedMorquio A Syndrome | MPS IVA | Mucopolysaccharidosis IV AUnited States, Canada, France, Taiwan, Argentina, Colombia, Spain, Turkey, Japan, Saudi Arabia, Netherlands, Denmark, Korea, Republic of, Brazil, United Kingdom, Germany, Norway, Portugal, Italy, Qatar
-
BioMarin PharmaceuticalCompletedAchondroplasiaUnited States, Australia, United Kingdom, Japan, Spain, Turkey
-
BioMarin PharmaceuticalCompletedTetrahydrobiopterin Deficiencies | Hyperphenylalaninemia, Non-PhenylketonuricGermany, United States
-
BioMarin PharmaceuticalCompletedPhenylketonuria (PKU)United States, Turkey, Canada, France, Germany, Italy, United Kingdom
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis IVA (Morquio A Syndrome)Australia
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
BioMarin PharmaceuticalCompletedBatten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky DiseaseUnited States, Italy, Germany, United Kingdom
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
BioMarin PharmaceuticalCompletedPompe DiseaseUnited States, United Kingdom, France, Australia, Germany
-
BioMarin PharmaceuticalTerminatedPompe DiseaseUnited States, United Kingdom, Australia, France, Germany, New Zealand
-
BioMarin PharmaceuticalTerminatedPhenylketonuriaItaly, Switzerland
-
BioMarin PharmaceuticalTerminatedDuchenne Muscular DystrophyBelgium, Netherlands, Italy, Sweden
-
BioMarin PharmaceuticalApproved for marketingCLN2 DiseaseUnited Kingdom, United States, Germany, Italy
-
BioMarin PharmaceuticalTerminatedMorquio A Syndrome | MPS IVA | Mucopolysaccharidosis IVAUnited States, United Kingdom, Canada, Germany
-
BioMarin PharmaceuticalApproved for marketingMorquio A Syndrome | MPS IVA | Mucopolysaccharidosis IVAUnited States, Puerto Rico
-
BioMarin PharmaceuticalCompletedStudy of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006PhenylketonuriaUnited States
-
BioMarin PharmaceuticalRecruitingDuchenne Muscular DystrophyUnited Kingdom
-
BioMarin PharmaceuticalRecruiting
-
BioMarin PharmaceuticalRecruitingHypochondroplasiaUnited States, Canada, France, Australia, Japan, Argentina, Brazil, Germany, Italy, Spain
-
BioMarin PharmaceuticalRecruitingNonalcoholic Fatty Liver Disease | Kidney Stone | HyperoxaluriaUnited States
-
BioMarin PharmaceuticalRecruiting
-
BioMarin PharmaceuticalRecruitingHereditary Angioedema | HAEUnited States, Spain, Australia
-
BioMarin PharmaceuticalActive, not recruitingLate-Infantile Neuronal Ceroid Lipofuscinosis Type 2United States
-
BioMarin PharmaceuticalActive, not recruitingPhenylketonuria (PKU)United States, Germany
-
BioMarin PharmaceuticalActive, not recruitingHemophilia AUnited States, Taiwan, United Kingdom, Australia, Israel, Belgium, Brazil, France, Germany, Italy, Korea, Republic of, South Africa, Spain
-
BioMarin PharmaceuticalActive, not recruiting
-
BioMarin PharmaceuticalActive, not recruitingAchondroplasiaUnited States, Australia, Germany, Spain, United Kingdom, Japan, Turkey
-
BioMarin PharmaceuticalActive, not recruitingAchondroplasiaUnited States, Australia, France, United Kingdom
-
BioMarin PharmaceuticalTerminatedAchondroplasiaUnited States
-
BioMarin PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedBatten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky Disease | CLN2 DisorderUnited States, Germany, Italy, United Kingdom
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe DiseaseUnited States, United Kingdom
-
BioMarin PharmaceuticalCompletedAchondroplasiaUnited States, Australia, United Kingdom, Japan
-
BioMarin PharmaceuticalCompletedPhenylketonuria | HyperphenylalaninaemiaUnited States
-
BioMarin PharmaceuticalCompletedBatten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky Disease | CLN2 DisorderUnited States, Germany, Italy, United Kingdom
-
BioMarin PharmaceuticalCompletedPhenylketonuria (PKU)United States
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
BioMarin PharmaceuticalCompletedPhenylketonuria (PKU)United States